Search Ontology:
ChEBI

beta-L-Fucp-(1->4)-[beta-D-Glcp-(1->3)]-D-Galp

Term ID
CHEBI:149106
Synonyms
  • (2R,3S,4R,5S,6S)-2-[(2R,3S,4R,5R)-5,6-dihydroxy-2-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
  • 6-deoxy-beta-L-galactopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->3)]-D-galactopyranose
  • beta-D-gluco-hexopyranosyl-(1->3)-[6-deoxy-beta-L-galacto-hexopyranosyl-(1->4)]-D-galacto-hexopyranose
  • beta-L-fucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->3)]-D-galactopyranose
  • Glc(b1-3)[Fuc(b1-4)]Gal
  • WURCS=2.0/3,3,2/[a2112h-1x_1-5][a2122h-1b_1-5][a1221m-1b_1-5]/1-2-3/a3-b1_a4-c1
Definition
A trisaccharide that is D-galactopyranose in which the hydroxy groups at positons 3 and 4 have been converted into the corresponding beta-D-glucopyranosyl and beta-L-fucopyranosyl derivatives, respectively.
References
  • GlyGen:G30982YZ
  • GlyTouCan:G30982YZ
  • KEGG:G03336
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-L-Fucp-(1->4)-[beta-D-Glcp-(1->3)]-D-Galp
Phenotype where environments contain beta-L-Fucp-(1->4)-[beta-D-Glcp-(1->3)]-D-Galp
Phenotype modified by environments containing beta-L-Fucp-(1->4)-[beta-D-Glcp-(1->3)]-D-Galp
Phenotype affecting beta-L-Fucp-(1->4)-[beta-D-Glcp-(1->3)]-D-Galp
Human Disease Model